| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.44 | 0.1 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |